Hip Muscle Strength in FAI Versus Normal Controls

Sponsor

Cambridge University Hospitals NHS Foundation Trust (Other)

Overall Status

Unknown status

CT.gov ID

NCT02697097

Collaborator

(none)

Enrollment

Location

Duration (Months)

1.3

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Hip Muscle Strength in femoro-acetabular impingement participants versus normal controls.

To investigate the hip muscle strength in a normal control group and compare this to patients who have a diagnosis of femoro-acetabular impingement (diagnosed clinically and with confirmed radiological features).

Condition or Disease	Intervention/Treatment	Phase
Femoro-acetabular Impingement

Study Design

Study Type:

Observational

Anticipated Enrollment :

20 participants

Observational Model:

Case-Control

Time Perspective:

Prospective

Official Title:

Muscle Strength in Femoroacetabular Impingement: A Comparative Study of Patients With FAI Versus Normal Controls

Study Start Date :

Apr 1, 2016

Anticipated Primary Completion Date :

Apr 1, 2017

Anticipated Study Completion Date :

Aug 1, 2017

Arms and Interventions

Arm	Intervention/Treatment
Control Arm Group Participants aged 18-30, Male and Female (10 participants each). Control group must have normal range of movement and no evidence of femoro-acetabular impingement (FAI) on clinical examination (negative impingement test, no symptoms). Other exclusions for Control Group include previous surgery to hip joint/s, history of arthritis, family history of FAI, patients who have had symptoms of hip pain in the preceding 1 year or may have other conditions which may affect the hip joint or hip muscle strength including neurological conditions or muscular dystrophy.
FAI Arm Comparison Group Participants aged 18-30, Male and Female (10 participants each). Participants with femoro-acetabular impingement as diagnosed clinically and on radiological imaging for the comparison group (MRI).

Arm

Intervention/Treatment

Control Arm Group

Participants aged 18-30, Male and Female (10 participants each). Control group must have normal range of movement and no evidence of femoro-acetabular impingement (FAI) on clinical examination (negative impingement test, no symptoms). Other exclusions for Control Group include previous surgery to hip joint/s, history of arthritis, family history of FAI, patients who have had symptoms of hip pain in the preceding 1 year or may have other conditions which may affect the hip joint or hip muscle strength including neurological conditions or muscular dystrophy.

FAI Arm Comparison Group

Participants aged 18-30, Male and Female (10 participants each). Participants with femoro-acetabular impingement as diagnosed clinically and on radiological imaging for the comparison group (MRI).

Outcome Measures

Primary Outcome Measures

Muscle Strength on Dynamometer [3 months]

Secondary Outcome Measures

Kinematics of the Hip - Range of Movement [3 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years to 30 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

Males and Females.
Aged 18-30.
Control group - Normal range of movement and no evidence of femoro-acetabular impingement on clinical examination (negative impingement test, no symptoms).
Participants with femoro-acetabular impingement as diagnosed clinically and on radiological imaging for the comparison group (MRI).

Exclusion Criteria:

Patients under the age of 18.
Patients over the age of 30.
Control group - evidence of underlying pathology affecting the hip, abnormal range of motion, evidence of femoro-acetabular impingement on clinical examination.
Previous surgery of the hip joints.
Medical history of arthritis (including rheumatoid and reactive).
Family history of femoro-acetabular impingement (control arm participants).
Patients who are currently experiencing or have experienced hip pain in the previous 1 year (control arm).
Other conditions (e.g. neurological, muscular dystrophy etc) which may affect hip muscle strength.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Addenbrooke's Hospital	Cambridge	Cambridgeshire	United Kingdom	CB2 0QQ

Sponsors and Collaborators

Cambridge University Hospitals NHS Foundation Trust

Investigators

Principal Investigator: Vikas Khanduja, MA, FRCS (Orth), Consultant Trauma and Orthopaedic Surgeon - Principal Investigator

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Vikas Khanduja MA FRCS (Orth), Principal Investigator, Cambridge University Hospitals NHS Foundation Trust

ClinicalTrials.gov Identifier:

NCT02697097

Other Study ID Numbers:

AddenbrookesH

First Posted:

Mar 3, 2016

Last Update Posted:

Mar 3, 2016

Last Verified:

Feb 1, 2016

Individual Participant Data (IPD) Sharing Statement:

Plan to Share IPD:

Keywords provided by Vikas Khanduja MA FRCS (Orth), Principal Investigator, Cambridge University Hospitals NHS Foundation Trust

Hip Muscle Strength

FAI

Additional relevant MeSH terms:

Femoracetabular Impingement

Study Results

No Results Posted as of Mar 3, 2016